Statement Of Financial Position [Abstract]

Innate Pharma - Filing #2811003

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Intangible assets other than goodwill
416,000 EUR
1 556 EUR
Trade and other non-current receivables
10 554 EUR
14 099 EUR
Deferred tax assets
9 006 EUR
8 568 EUR
Other non-current non-financial assets
87,000 EUR
149,000 EUR
Non-current assets
36 181 EUR
68 033 EUR
Current assets [abstract]
Trade and other current receivables
55 557 EUR
38 346 EUR
Cash and cash equivalents
70 605 EUR
84 225 EUR
103 756 EUR
Current assets
148 012 EUR
139 831 EUR
Assets
184 193 EUR
207 863 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
4 044 EUR
4 011 EUR
Share premium
384 255 EUR
379 637 EUR
Equity
384 255 EUR
4 044 EUR
495,000 EUR
329 323 EUR
51 901 EUR
7 570 EUR
54 151 EUR
379 637 EUR
272 213 EUR
4 011 EUR
58 103 EUR
819,000 EUR
107 440 EUR
219 404 EUR
52 809 EUR
456,000 EUR
375 220 EUR
3 978 EUR
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current provisions [abstract]
Non-current provisions for employee benefits
2 441 EUR
2 550 EUR
Non-current provisions
603,000 EUR
198,000 EUR
Deferred tax liabilities
9 006 EUR
8 568 EUR
Non-current liabilities
92 656 EUR
112 374 EUR
Current liabilities [abstract]
Current provisions [abstract]
Current provisions
171,000 EUR
1 542 EUR
Trade and other current payables
17 018 EUR
20 911 EUR
Current liabilities
39 637 EUR
41 338 EUR
Equity and liabilities
184 193 EUR
207 863 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.